human
collectin
mannosebind
lectin
mbl
import
protein
humor
innat
immun
system
multipl
carbohydraterecognit
domain
abl
bind
sugar
group
display
surfac
wide
rang
microorgan
therebi
provid
firstlin
defenc
importantli
also
activ
complement
system
distinct
third
pathway
independ
antibodi
complex
three
singl
point
mutat
exon
express
human
gene
appear
impair
gener
function
oligom
defici
function
protein
common
certain
popul
eg
subsaharan
africa
virtual
absent
other
eg
indigen
australian
mbl
diseas
associ
studi
fruit
area
research
implic
role
mbl
infect
inflammatori
autoimmun
diseas
process
overal
appear
genet
balanc
individu
gener
benefit
high
level
protein
howev
certain
situat
reduc
level
circul
mbl
may
benefici
host
may
explain
persist
deleteri
gene
polymorph
mani
popul
group
year
sinc
australian
nobel
prize
winner
sir
frank
macfarlan
burnet
togeth
john
mccrea
identifi
three
inhibitor
serum
call
b
g
abl
inactiv
influenza
viru
know
b
inhibitor
fact
protein
call
mannosebind
lectin
mbl
compon
innat
immun
system
past
year
understand
protein
steadili
increas
result
extens
research
activ
three
main
area
bioimmunochemistri
includ
molecular
genet
b
microbiolog
c
immunodefici
work
area
initi
proceed
independ
evid
inexplic
biolog
function
clinic
defici
state
emerg
isol
character
protein
necessari
order
illumin
observ
socal
rarf
bactericid
activ
microbiolog
area
opson
defici
report
mani
paediatr
popul
main
develop
summar
tabl
review
briefli
address
issu
relat
earli
histori
mbl
structur
function
genet
diseas
associ
final
futur
develop
includ
potenti
use
plasmaderiv
recombin
mbl
discuss
exist
mammalian
serum
lectin
first
predict
robinson
et
al
protein
first
isol
cytosol
fraction
rabbit
liver
kawasaki
et
al
subsequ
wild
et
al
abl
isol
mbl
human
rat
liver
recent
extrahepat
transcript
mbl
report
may
implic
regard
role
local
host
defenc
mbl
belong
famili
protein
call
collectin
possess
collagen
region
lectin
domain
major
human
collectin
surfact
protein
surfact
protein
possess
structur
characterist
similar
mbl
found
predominantli
lung
mucos
site
plasmaassoci
phagocyt
defect
exist
mammalian
serum
protein
specif
predict
associ
opson
defect
frequent
infect
infanc
defici
also
present
gener
popul
mbl
isol
rabbit
liver
opson
defici
infant
chronic
diarrhoea
associ
yeast
opson
defect
suboptim
deposit
descript
mous
rarf
complementactiv
bactericid
protein
human
mbl
isol
liver
human
serum
mbl
isol
prospect
studi
opson
defici
infanc
rarf
activ
present
vertebr
class
bovin
serum
mbl
describ
opson
defect
link
absenc
unidentifi
cofactor
complement
system
mbl
activ
classic
complement
pathway
rat
serum
mbl
c
describ
descript
ctype
crd
gene
human
mbl
clone
human
mbl
bactericid
activ
opson
natur
mbl
demonstr
mbl
inhibit
vitro
infect
hiv
correl
opson
defect
low
serum
mbl
level
bovin
mous
serum
b
inhibitor
influenza
viru
identifi
mbl
correl
mbl
level
classic
complement
pathway
activ
low
serum
concentr
mous
mbl
c
describ
opson
defici
low
mbl
level
link
singl
point
mutat
codon
variant
b
human
mbl
level
acutephas
respons
crystallographi
mbl
crd
novel
proteas
complement
activ
mbl
human
rarf
ident
mblmasp
low
mbl
level
african
link
codon
variant
c
mutat
mbl
gene
third
mbl
mutat
codon
variant
describ
polymorph
found
promot
region
mbl
gene
second
masp
found
activ
complement
mbl
mutat
import
risk
factor
infect
children
reconstitut
opson
activ
infus
purifi
mbl
mbldefici
human
truncat
form
complementactiv
complex
ficolin
masp
mbl
shown
bind
clinic
relev
organ
structur
aspect
mbl
protein
structur
mbl
studi
extens
aspect
present
figur
protein
consist
multim
ident
polypeptid
chain
kda
chain
compris
four
distinct
region
encod
differ
exon
gene
discuss
detail
later
chain
ctermin
calciumdepend
carbohydraterecognit
domain
crd
short
ahel
hydrophob
neck
region
socal
coiledcoil
configur
collagen
region
contain
glyxaaxaa
triplet
cysteinerich
ntermin
region
three
polypeptid
chain
form
tripl
helix
within
collagen
region
stabil
hydrophob
interact
interchain
disulphid
bond
within
ntermin
cysteinerich
region
basic
build
block
circul
molecular
form
mbl
serum
mbl
consist
oligom
rang
dimer
hexam
xray
crystallograph
studieselectron
micrograph
reveal
oligom
sertiform
bouquetlik
structur
due
interrupt
collagen
region
give
rise
kinkhing
abil
protein
bind
effect
microorgan
activ
complement
appear
depend
presenc
higher
order
oligom
tetram
work
drickam
colleagu
also
ezekowitz
colleagu
provid
insight
structur
crd
crd
bind
calcium
ion
enabl
form
coordin
bond
group
specif
sugar
includ
mannos
nacetyldglucosamin
nacetylmannosamin
fucos
glucos
three
crd
structur
subunit
separ
constant
distanc
cluster
structur
subunit
provid
flat
platform
permit
bind
mbl
array
repeat
sugar
group
microbi
surfac
although
bind
affin
individu
crdsugar
interact
rel
low
format
higher
order
oligom
provid
multipl
crd
abl
bind
simultan
high
avid
mbl
major
patternrecognit
molecul
innat
immun
system
primarili
recogn
specif
sugar
group
surfac
microorgan
enabl
distinguish
self
nonself
also
bind
phospholipid
nucleic
acid
nonglycosyl
protein
mbl
shown
bind
promiscu
wide
rang
bacteria
virus
fungi
protozoa
select
exampl
list
tabl
neth
et
al
use
flow
cytometri
demonstr
mbl
bind
clinic
relev
bacteri
isol
immunocompromis
children
note
differ
bind
within
speci
one
isol
might
show
strong
bind
wherea
anoth
much
weaker
role
specif
structur
featur
microorgan
eg
capsul
permit
prevent
bind
mbl
explor
sever
studi
earliest
work
probabl
kawakami
et
al
socal
rarf
complex
later
identifi
mbl
interact
salmonella
enterica
serovar
typhimurium
suggest
structur
composit
lipopolysaccharid
play
crucial
role
mbl
bind
function
mechan
enabl
microorgan
avoid
recognit
kill
mbl
includ
lipooligosaccharid
sialyat
despit
much
progress
area
mani
puzzl
remain
address
mostli
relat
exact
disposit
sugar
microbi
surfac
understand
mbl
function
grown
rapidli
past
three
decad
recogn
role
process
divers
complement
activ
promot
complementindepend
opsonophagocytosi
modul
inflamm
recognit
alter
selfstructur
apoptot
cell
clearanc
role
mbl
host
defenc
first
propos
ikeda
et
al
observ
protein
abl
activ
classic
pathway
complement
howev
clear
mbl
activ
novel
third
pathway
complement
often
term
mbl
pathway
antibodyand
fashion
illustr
figur
function
activ
reflect
fact
mbl
circul
associ
group
mblassoci
serin
proteas
socal
masp
matsushita
fujita
demonstr
presenc
novel
complement
enzym
serum
thought
gener
convertas
associ
classic
pathway
activ
howev
activ
later
found
mediat
origin
enzym
known
may
activ
directli
subsequ
small
separ
synthes
fragment
term
smap
identifi
third
masp
known
function
also
describ
current
understand
suggest
bind
microorgan
autoactiv
occur
permit
cleavag
form
convertas
indistinguish
specif
convertas
found
two
activ
pathway
complement
note
socal
mbl
pathway
also
activ
anoth
famili
protein
call
ficolin
ficolin
structur
similar
collectin
collagen
domain
link
fibrinogenlik
domain
sugarbind
properti
land
hficolin
humor
factor
synthes
hepatocyt
although
hficolin
also
observ
bronchialalveolar
fluid
bile
contrast
mficolin
found
peripher
blood
mononuclear
cell
polymorphonuclear
cell
type
ii
lung
epitheli
cell
ficolin
also
found
complex
masp
consid
differ
bind
specif
compar
mbl
miller
et
al
report
plasmaassoci
defect
phagocytosi
child
sever
recurr
infect
failur
thrive
diarrhoea
vitro
work
reveal
failur
plasma
opson
heatkil
baker
yeast
saccharomyc
cerevisia
defect
later
detect
sera
children
recurr
unexplain
infect
chronic
diarrhoea
infanc
interestingli
studi
gener
popul
also
reveal
rel
high
frequenc
defect
studi
link
opson
defici
complement
figur
complement
activ
pathway
lectin
pathway
complement
activ
mbl
ficolin
bind
appropri
target
complex
cleav
form
convertas
complex
may
activ
directli
ficolin
also
work
combin
masp
classic
altern
pathway
also
gener
convertas
enzym
cleav
lytic
pathway
common
three
rout
cleavag
mbl
mannosebind
lectin
masp
mblassoci
serin
proteas
mblassoci
serin
mblassoci
serin
system
demonstr
sera
defici
deposit
less
yeast
surfac
howev
common
opson
defect
found
associ
low
level
mannosebind
protein
refer
mbl
year
gene
mbl
clone
genet
human
mbl
studi
mblcoat
salmonella
montevideo
kuhlman
et
al
report
mbl
abl
interact
directli
cell
surfac
receptor
promot
opsonophagocytosi
subsequ
number
put
mblbind
proteinsreceptor
propos
includ
calreticulin
howev
unclear
whether
mbl
act
direct
opsonin
mere
enhanc
complement
pathway
andor
antibodymedi
phagocytosi
role
mbl
modul
inflamm
appear
complex
accordingli
mechan
action
remain
unexplain
one
possibl
explan
mbl
abl
trigger
proinflammatori
cytokin
releas
monocyt
concept
address
studi
jack
et
al
use
neisseria
meningitidi
incub
increas
concentr
mbl
ad
mbldefici
whole
blood
releas
tumour
necrosi
factor
interleukin
il
monocyt
enhanc
mbl
concentr
mgml
suppress
higher
concentr
clinic
studi
area
discuss
later
role
mbl
recognit
alter
self
apoptosi
role
mbl
clearanc
apoptot
cell
first
propos
ogden
et
al
mbl
found
bind
directli
apoptot
cell
expos
termin
sugar
cytoskelet
protein
therebi
permit
recognit
directli
facilit
phagocytosi
macrophag
defect
clearanc
apoptot
cell
implic
pathogenesi
certain
autoimmun
condit
although
precis
role
mbl
remain
elus
exampl
stuart
et
al
report
although
mbldefici
mice
display
defect
apoptot
cell
clearanc
develop
autoimmun
diseas
anim
studi
mbl
implic
pathophysiolog
ischaemia
reperfus
injuri
due
abil
recogn
alter
selfstructur
stahl
colleagu
propos
lectin
pathway
mediat
process
certain
organ
absenc
mblmasp
pathway
activ
appear
afford
protect
diseas
model
howev
relev
find
human
health
need
establish
chang
cell
surfac
structur
oncogen
transform
appear
promot
bind
mbl
cancer
cell
protein
mediat
cytotox
effect
includ
mbldepend
cell
mediat
cytotox
rel
import
mechan
tumour
immunolog
present
unknown
two
human
mbl
gene
pseudogen
encod
protein
product
function
gene
locat
chromosom
compris
four
exon
illustr
figur
exon
encod
signal
peptid
cysteinerich
region
part
glycinerich
collagen
region
exon
encod
remaind
collagen
region
exon
encod
ahel
coiledcoil
structur
known
region
exon
encod
crd
adopt
globular
configur
promot
region
mbl
gene
contain
number
regulatori
element
affect
transcript
protein
complet
nucleotid
sequenc
four
exon
human
gene
determin
sumiya
et
al
two
british
children
recurr
infect
low
mbl
level
individu
point
mutat
observ
codon
chang
codon
sequenc
ggc
gac
substitut
aspart
acid
glycin
translat
protein
famili
studi
confirm
defect
inherit
autosom
domin
fashion
lipscomb
et
al
identifi
second
exon
mutat
codon
gli
glu
studi
subsaharan
african
popul
madsen
et
al
report
mutat
codon
arg
cy
point
mutat
commonli
refer
variant
b
c
respect
variant
indic
wild
type
b
variant
mutat
occur
gene
frequenc
approxim
eurasian
popul
contrast
c
variant
rare
eurasian
commonli
seen
subsaharan
african
popul
frequenc
popul
studi
suggest
b
variant
mutat
may
arisen
year
ago
sinc
structur
gene
mutat
identifi
studi
indigen
australian
popul
arriv
contin
approxim
year
ago
wherea
b
variant
mutat
probabl
introduc
north
south
america
time
last
glaciat
approxim
year
ago
effect
exon
mutat
protein
product
continu
focu
studi
believ
impair
oligomer
lead
function
defici
b
c
mutat
result
replac
critic
axial
glycin
tripl
helix
dicarboxyl
acid
result
distort
import
part
protein
contrast
mutat
result
replac
arginin
cystein
extra
cystein
propos
caus
format
adventiti
disulphid
bond
hinder
higher
oligom
format
sever
polymorph
also
report
promot
region
gene
studi
madsen
et
al
investig
larg
interindividu
variat
serum
mbl
level
reveal
three
polymorph
hl
xy
pq
posit
mbl
gene
subsequ
four
common
haplotyp
identifi
name
lxp
lyp
lyq
hyp
hyp
associ
medium
high
level
mbl
lxp
associ
low
level
protein
appear
import
promot
haplotyp
strong
linkag
disequilibrium
exon
mutat
result
seven
common
extend
haplotyp
name
hypa
lypa
lyqa
lxpa
hypd
lypb
lyqc
rare
haplotyp
also
describ
figur
illustr
frequenc
variou
haplotyp
select
popul
highlight
degre
ethnic
variat
combin
structur
gene
promot
polymorph
result
dramat
variat
mbl
concentr
appar
healthi
individu
caucasian
rang
ngml
addit
ezekowitz
colleagu
present
evid
mbl
acutephas
reactant
investig
rna
isol
liver
taken
part
stage
biopsi
hodgkin
diseas
compar
rna
isol
fresh
postmortem
liver
victim
sever
trauma
author
found
mbl
messeng
rna
transcript
bare
detect
normal
liver
induct
seen
liver
expos
acut
stress
subsequ
studi
shown
mbl
level
increas
threefold
acut
phase
respons
variabl
individu
also
note
even
acutephas
respons
individu
heterozyg
homozyg
mbl
mutat
appear
unabl
achiev
protein
level
possess
wildtyp
genotyp
approxim
onethird
caucasian
popul
possess
genotyp
confer
low
level
mbl
approxim
low
level
absolut
level
mbl
defici
defin
genotyp
phenotyp
show
rel
strong
correl
studi
often
use
one
measur
infer
defici
howev
perform
measur
would
strongli
advoc
approach
whenev
possibl
mbl
occur
two
distinct
form
rodent
rhesu
monkey
one
form
found
human
chicken
discuss
previous
two
human
mbl
gene
like
due
gene
duplic
event
howev
pseudogen
potenti
mechan
respons
silenc
substitut
also
found
higher
primat
includ
chimpanze
gorilla
distant
primat
rhesu
monkey
author
conclud
gene
select
silenc
molecular
mechan
skew
time
result
overal
downregul
mbl
level
present
human
popul
high
frequenc
variant
allel
observ
certain
popul
initi
puzzl
sinc
suggest
function
mbl
defici
may
well
advantag
similar
propos
mbl
genet
system
role
sickl
cell
gene
protect
malaria
occur
carrier
sickl
cell
haemoglobin
allel
argument
run
follow
certain
intracellular
parasit
use
opson
receptor
monocytesmacrophag
enter
host
therefor
reduct
complementactiv
function
host
may
reduc
probabl
parasit
support
notion
studi
patient
viscer
leishmaniasi
reveal
patient
like
high
mbl
level
uninfect
control
small
studi
ethiopian
patient
lepromat
borderlin
lepromat
leprosi
also
found
mbl
level
significantli
higher
healthi
blood
donor
altern
explan
unexpectedli
high
frequenc
low
mbl
phenotyp
individu
found
mani
tropic
region
excess
complement
activ
result
immunopatholog
mediat
host
damag
therefor
mechan
reduc
complement
activ
may
benefici
identif
mbl
defici
caus
socal
common
opson
defect
follow
plethora
diseas
associ
studi
aim
defin
precis
role
protein
number
earli
studi
concentr
paediatr
popul
mbl
suggest
provid
substitut
activ
approxim
month
matern
immunoglobulin
g
igg
antibodi
level
wane
adapt
immun
respons
still
immatur
nevertheless
studi
adult
suggest
might
role
mbl
throughout
life
notwithstand
report
major
individu
possess
variant
mbl
allel
appar
suffer
ill
effect
remain
essenti
healthi
studi
appar
confirm
dahl
et
al
monitor
adult
danish
caucasian
popul
found
evid
signific
differ
infecti
diseas
mortal
mbldefici
individu
compar
control
similar
find
report
tacx
et
al
unselect
adult
admit
hospit
infect
nevertheless
studi
regard
proof
mbl
level
clinic
relev
mani
group
undertaken
casecontrol
studi
inde
suggest
mbl
import
immunolog
modul
case
evid
signific
mbl
defici
readili
appreci
anoth
coexist
defect
first
propos
space
permit
comprehens
review
mbl
clinic
studi
undertaken
date
topic
cover
select
order
illustr
exampl
possibl
role
mbl
varieti
clinic
situat
studi
explor
role
mbl
relat
acquisit
infecti
organ
suscept
natur
associ
clinic
cours
sever
clinic
practic
distinct
difficult
howev
purpos
review
highlight
exampl
infect
mbl
appear
influenc
one
two
aspect
infecti
diseas
hamva
et
al
recent
shown
role
mbl
mycoplasma
infect
studi
case
infect
patient
primari
antibodi
defici
pad
known
particularli
suscept
organ
compar
control
popul
twothird
pad
patient
mycoplasma
infect
mbl
defici
possess
exon
variant
allel
compar
onethird
control
group
studi
abl
demonstr
bind
mbl
three
strain
mycoplasma
use
flow
cytometri
propos
role
mbl
prevent
invas
diseas
sever
acut
respiratori
syndrom
sar
emerg
highli
infecti
diseas
caus
novel
coronaviru
sarscov
provid
new
challeng
previous
unexpos
individu
predominantli
asia
specif
antibodi
sarscov
could
detect
day
onset
symptom
make
suffer
reliant
innat
immun
mechan
earli
phase
infect
sinc
structur
viru
rapidli
establish
also
becam
clear
novel
infecti
agent
rich
sugar
known
target
mbl
hypothes
lectin
might
well
involv
firstlin
defenc
infect
subsequ
studi
found
signific
differ
distribut
mbldefici
genotyp
patient
sar
compar
control
studi
suggest
mbl
play
role
suscept
infect
influenc
subsequ
sever
investig
ip
et
al
also
abl
demonstr
bind
mbl
viru
abil
inhibit
infect
b
variant
allel
found
commonli
patient
symptomat
hepat
b
cirrhosi
spontan
bacteri
periton
also
note
mbl
level
lower
patient
cohort
chronic
infect
screen
mbl
mutat
patient
suggest
order
enabl
identif
increas
risk
complic
may
benefit
prophylact
antibiot
treatment
chong
et
al
also
report
mbl
genotyp
correl
low
protein
level
associ
occurr
cirrhosi
also
hepatocellular
carcinoma
hepat
b
carrier
also
demonstr
mbl
abl
bind
hepat
b
surfac
antigen
year
thio
et
al
publish
result
nest
casecontrol
studi
patient
either
natur
recov
hepat
b
n
persist
infect
n
found
mbl
genotyp
correl
high
serum
level
associ
recoveri
infect
wherea
correl
lower
level
associ
persist
viru
note
approxim
half
subject
also
infect
human
immunodefici
viru
hiv
author
conclud
influenc
result
obtain
matsushita
et
al
investig
influenc
mbl
mutat
hepat
c
infect
found
suffer
homozyg
b
variant
allel
less
like
respond
interferon
treatment
work
would
warrant
order
defin
role
mbl
pathogenesi
hepat
infect
secondari
immunodefici
due
diseas
treatment
provid
interest
patient
popul
within
studi
role
mbl
one
group
compris
receiv
chemotherapi
malign
patient
render
neutropen
treatment
underli
diseas
process
subsequ
increas
risk
infecti
complic
two
studi
publish
report
effect
mbl
defici
patient
neth
et
al
studi
children
measur
mbl
level
genotyp
children
possess
mbl
variant
allel
spent
twice
mani
day
hospit
febril
neutropenia
first
month
treatment
compar
wildtyp
individu
studi
peterslund
et
al
follow
adult
undergo
chemotherapi
variou
haematolog
malign
found
develop
infect
bacteraemia
pneumonia
period
posttreat
significantli
lower
level
mbl
compar
without
signific
infect
subsequ
studi
shown
differ
result
draw
comparison
inher
difficult
patient
highli
heterogen
popul
differ
underli
diseas
process
undergo
treatment
regimen
differ
intens
result
variou
degre
immunosuppress
one
contrast
studi
bergmann
et
al
follow
adult
undergo
therapi
acut
myeloid
leukaemia
involv
intens
highli
myelosuppress
treatment
found
effect
mbl
defici
frequenc
sever
durat
fever
suggest
natur
treatment
overwhelm
potenti
influenc
mbl
clinic
studi
patient
requir
order
delin
exact
role
mbl
mbl
doubleknockout
mous
model
use
explor
clinic
conundrum
shi
et
al
demonstr
mbl
null
mice
highli
suscept
intraven
inocul
staphylococcu
aureu
die
within
h
compar
surviv
mbl
wildtyp
mice
howev
mice
inocul
via
intraperiton
rout
render
neutropen
use
cyclophosphamid
neutropen
mbl
null
mice
found
higher
accumul
bacteria
blood
organ
compar
neutropen
wildtyp
mice
day
postinfect
neutropen
wildtyp
mice
clear
blood
neutropen
mbl
null
mice
persist
bacteraemia
author
abl
revers
phenotyp
treat
mbl
null
mice
recombin
mbl
date
nearli
million
human
infect
hiv
clinic
consequ
viral
exposur
variabl
individu
repeatedli
expos
viru
remain
free
infect
other
infect
remain
free
clinic
diseas
numer
viral
host
factor
determin
fate
individu
expos
hiv
data
indic
mbl
influenc
suscept
sever
hiv
infect
like
target
hiv
bind
heavili
glycosyl
glycoprotein
mbl
readili
demonstr
bind
purifi
capac
mbl
neutral
primari
hiv
isol
less
convinc
recent
data
indic
mbl
opson
hiv
induc
neutral
level
normal
present
serum
howev
bind
opson
hiv
mbl
may
alter
viru
traffick
viral
antigen
present
hiv
infect
mbl
may
influenc
uptak
dendrit
cell
dc
express
cell
surfac
lectin
call
intracellular
adhes
molecul
dcsign
dcsign
shown
mediat
type
infect
call
dc
bind
hiv
effici
transfer
viru
cell
preincub
hiv
strain
mbl
prevent
dcsignmedi
transinfect
cell
indic
least
vitro
mbl
may
inhibit
dcsignmedi
uptak
spread
hiv
whatev
mechan
mbl
interact
hiv
number
clinic
studi
suggest
defici
mbl
risk
factor
acquir
hiv
infect
mbl
defici
appear
increas
acquisit
hiv
infect
threeand
eightfold
also
increas
risk
vertic
transmiss
infect
mother
offspr
howev
find
replic
popul
studi
fail
demonstr
role
mbl
hiv
infect
even
less
clariti
regard
role
mbl
hiv
diseas
progress
gar
et
al
demonstr
men
mbl
variant
allel
shorter
surviv
time
follow
onset
acquir
immun
defici
syndrom
aid
patient
wildtyp
mbl
allel
howev
wellcharacter
cohort
homosexu
men
variant
mbl
allel
insignific
effect
surviv
follow
diagnosi
aid
latter
studi
appear
protect
effect
mbl
variant
allel
delay
develop
aid
time
hiv
seroconvers
patient
mbl
variant
allel
lower
count
time
develop
aid
indic
mbl
defici
may
influenc
onset
aid
given
count
furthermor
mbl
mutat
appear
protect
develop
kaposi
sarcoma
find
difficult
explain
anoth
studi
prohaszka
et
al
found
mbl
level
lower
asymptomat
hivposit
individu
compar
hivneg
control
howev
protect
effect
mbl
lost
patient
aid
diagnosi
patient
high
mbl
level
significantli
lower
number
cell
possibl
explan
enhanc
proinflammatori
cytokin
product
advanc
hiv
diseas
act
increas
mbl
synthesi
elev
level
patient
latestag
diseas
inde
recent
studi
shown
vitro
mbl
enhanc
proinflammatori
cytokin
product
viral
replic
light
studi
indic
role
mbl
inflammatori
modul
tempt
suggest
circumst
mbl
may
act
promot
inflammatori
cell
activ
therebi
acceler
rate
tcell
deplet
studi
assess
impact
mbl
context
effect
antivir
therapi
howev
one
studi
attempt
relat
mbl
statu
hivinfect
longterm
nonprogressor
ltnp
mbl
level
consist
wildtyp
genotyp
six
ltnp
studi
amoroso
colleagu
also
suggest
effect
studi
show
children
rapidli
progress
diseas
like
mbl
variant
allel
codon
slower
progressor
cystic
fibrosi
provid
exampl
clinic
condit
mbl
appear
exert
role
infect
suscept
gene
inflammatori
modul
gar
et
al
first
group
report
patient
mbl
variant
allel
significantli
impair
lung
function
decreas
life
expect
comparison
wildtyp
individu
effect
mbl
defici
sever
lung
diseas
appar
patient
chronic
pseudomona
aeruginosa
infect
also
found
burkholderia
cepacia
infect
common
patient
mbl
defici
davi
et
al
report
effect
mbl
seen
adult
homozyg
mbl
mutat
patient
significantli
reduc
lung
function
frequent
hospit
admiss
rais
system
inflammatori
marker
howev
evid
increas
suscept
burkholderia
cepacia
pseudomona
aeruginosa
whether
mbl
effect
earli
colon
burkholderia
cepacia
pseudomona
aeruginosa
subsequ
secondari
viral
infect
whether
anti
inflammatori
effect
subsequ
lung
damag
remain
unclear
clinic
studi
critic
ill
patient
requir
intens
care
manag
shown
individu
mbl
defici
like
develop
system
inflammatori
respons
syndrom
sir
figur
progress
septic
shock
death
find
may
well
relat
proinflammatori
cytokin
respons
also
note
chronic
inflamm
increasingli
accept
risk
factor
myocardi
infarct
mi
recent
studi
saevarsdottir
et
al
found
patient
high
mbl
level
decreas
likelihood
suffer
mi
suggest
potenti
role
mbl
modul
inflammatori
respons
compon
complement
system
similar
also
player
infecti
inflammatori
process
structur
function
mbl
prompt
studi
explor
possibl
role
autoimmun
condit
system
lupu
erythematosu
sle
focu
number
mbl
genotyp
studi
result
somewhat
inconsist
nevertheless
recent
metaanalysi
review
studi
area
found
mbl
variant
allel
inde
sle
risk
factor
infecti
diseas
evid
risk
patholog
increas
anoth
coexist
immun
defect
exampl
cohort
spanish
patient
odd
ratio
develop
sle
individu
mbl
defici
increas
also
coexist
partial
defici
studi
patient
sle
report
mbl
defici
also
influenc
risk
develop
certain
complic
includ
arteri
thrombos
respiratori
tract
infect
role
mbl
pathogenesi
rheumatoid
arthriti
also
suggest
malhotra
et
al
report
chang
igg
glycosyl
secondari
underli
diseas
result
mblassoci
complement
activ
complement
activ
contribut
chronic
inflamm
synovi
membran
howev
graudal
et
al
found
patient
lower
mbl
level
experienc
earlier
sever
symptom
rapid
joint
destruct
visual
radiolog
sever
recent
research
public
suggest
direct
futur
work
collectin
associ
molecul
may
proceed
includ
therapeut
intervent
function
assay
evalu
import
mbl
diseas
consid
briefli
therapeut
potenti
mbl
mbl
replac
first
attempt
without
knowledg
defici
fresh
frozen
plasma
given
patient
found
correct
opson
defect
sinc
affinitypurifi
plasmaderiv
mbl
safe
given
mani
patient
result
normal
enzymelink
immunosorb
assay
detect
mbl
complementmedi
opson
activ
phase
studi
show
halflif
protein
rang
h
develop
recombin
mbl
also
phase
trial
stage
develop
provid
excit
prospect
futur
explor
therapeut
potenti
mbl
exactli
would
benefit
replac
therapi
debat
import
target
welldefin
patient
group
vital
success
discoveri
compon
lectin
pathway
includ
ficolin
masp
indic
limb
immun
system
complex
extend
beyond
mbl
alon
knowledg
enabl
us
question
impact
molecul
either
isol
combin
function
assess
lectin
pathway
may
far
accur
clinic
relev
measur
mbl
level
andor
genotyp
alon
number
differ
assay
report
assess
activ
differ
stage
function
pathway
therefor
result
must
interpret
accordingli
impact
defici
variou
adjunct
compon
also
subject
much
current
research
stengaardpedersen
et
al
report
first
identifi
case
defici
function
analysi
abil
mbl
activ
lectin
pathway
estim
deposit
mannan
surfac
perform
group
patient
suspect
immunodefici
one
patient
found
defici
pathway
activ
despit
suffici
mbl
found
plasma
genet
analysi
indic
patient
homozyg
point
mutat
exon
gene
clinic
patient
suffer
recurr
infect
autoimmun
symptom
subsequ
frequenc
mutat
assess
small
number
popul
valu
rang
discuss
previous
contribut
pathway
remain
unexplain
role
ficolin
begin
address
clinic
studi
like
mbl
absolut
level
defici
yet
defin
atkinson
et
al
studi
children
recurr
respiratori
tract
infect
measur
lficolin
level
associ
mbl
defici
patient
cohort
alreadi
report
studi
low
level
lficolin
common
patient
control
common
patient
coexist
atop
disord
suggest
role
lficolin
protect
microorgan
complic
allerg
diseas
polymorph
ficolin
identifi
although
clinic
signific
yet
unknown
mbl
ancient
molecul
probabl
subject
larg
number
evolutionari
pressur
last
year
human
evolut
associ
major
chang
hominid
move
essenti
nomad
lifestyl
increasingli
crowd
live
arrang
larg
settl
commun
associ
chang
spectrum
common
infecti
diseas
would
also
chang
recent
introduct
antibiot
emerg
novel
infect
increas
use
immunosuppress
therapi
provid
new
challeng
innat
host
defenc
system
despit
chang
evolutionari
pressur
mbl
gene
polymorph
persist
high
frequenc
suggest
offer
potenti
advantag
host
thu
exist
balanc
certain
individu
benefit
express
high
level
protein
wherea
other
live
differ
environ
eg
tropic
may
benefit
reduc
level
circul
mbl
figur
mbl
statu
may
also
either
advantag
disadvantag
consid
viewpoint
sever
particular
ill
thu
known
higher
level
mbl
better
abl
modul
inflamm
probabl
effect
cytokin
respons
contrast
defici
mbl
appear
risk
sepsi
sir
reason
believ
analys
relev
mbl
extend
beyond
role
infecti
diseas
includ
clinic
area
autoimmun
inflammatori
disord
